346 related articles for article (PubMed ID: 7342385)
1. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
Ogunmekan DA; Harry TO
Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
[TBL] [Abstract][Full Text] [Related]
2. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
Harry TO; Ogunmekan DA
Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
[TBL] [Abstract][Full Text] [Related]
3. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
Kanra G; Ceyhan M
Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
[TBL] [Abstract][Full Text] [Related]
4. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
Oyefolu AO; Omilabu SA
West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
[TBL] [Abstract][Full Text] [Related]
5. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
6. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
[TBL] [Abstract][Full Text] [Related]
7. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.
Halsey NA; Boulos R; Mode F; Andre J; Bowman L; Yaeger RG; Toureau S; Rohde J; Boulos C
N Engl J Med; 1985 Aug; 313(9):544-9. PubMed ID: 4022091
[TBL] [Abstract][Full Text] [Related]
8. Measles antibody levels from birth to 9 months of age in Nigerian infants.
Abdurrahman MB; Greenwood BM; Olafimihan O; Whitle HC
Afr J Med Med Sci; 1982 Sep; 11(3):113-5. PubMed ID: 6307026
[TBL] [Abstract][Full Text] [Related]
9. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
10. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
Pannuti CS; de Souza VA; Sato HK; Fink MC; Ribeiro MI; Hisi SK; Castelo A; de Mendonça JS
Rev Inst Med Trop Sao Paulo; 1990; 32(6):450-5. PubMed ID: 2135492
[TBL] [Abstract][Full Text] [Related]
11. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age.
Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022
[TBL] [Abstract][Full Text] [Related]
12. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
13. The role of herd immunity in control of measles.
Black FL
Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
[TBL] [Abstract][Full Text] [Related]
14. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
16. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
[TBL] [Abstract][Full Text] [Related]
17. Trial of a reduced dose of measles vaccine in Nigerian children.
Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
[TBL] [Abstract][Full Text] [Related]
18. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
19. Age for measles immunization seroconversion after measles vaccination at 6-8 months of age--a randomized controlled trial.
Deivanayagam N; Ramamurthy N; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
Indian Pediatr; 1990 Nov; 27(11):1171-6. PubMed ID: 2081639
[TBL] [Abstract][Full Text] [Related]
20. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
